124344-94-1 Usage
General Description
1-METHYL-5-PHENYL-1H-PYRAZOLE-3-CARBALDEHYDE is a chemical compound with the molecular formula C11H10N2O. It is a pyrazole derivative, which is a five-membered heterocyclic ring containing two nitrogen atoms at positions 1 and 2. The compound contains a carbonyl group attached to the third carbon of the pyrazole ring. It is commonly used as a building block in the synthesis of various pharmaceuticals and organic compounds. The compound has been studied for its potential biological activities, including its antioxidant and anti-inflammatory properties. Additionally, it has been investigated for its potential applications in material science, such as in the fabrication of organic light-emitting diodes (OLEDs) and organic photovoltaic devices.
Check Digit Verification of cas no
The CAS Registry Mumber 124344-94-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,4,3,4 and 4 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 124344-94:
(8*1)+(7*2)+(6*4)+(5*3)+(4*4)+(3*4)+(2*9)+(1*4)=111
111 % 10 = 1
So 124344-94-1 is a valid CAS Registry Number.
InChI:InChI=1/C11H10N2O/c1-13-11(7-10(8-14)12-13)9-5-3-2-4-6-9/h2-8H,1H3
124344-94-1Relevant articles and documents
Azaindoles
-
Page/Page column 117, (2008/06/13)
The invention is directed to compositions containing physiologically active compounds of general formula (I): wherein R1 is aryl or heteroaryl; R2 represents hydrogen, acyl, cyano, halo, lower alkenyl or lower alkyl optionally substituted by a substituent selected from cyano, heteroaryl, heterocycloalkyl, —Z1R8, —C(═O)—NY3Y4, —CO2R8, —NY3Y4, —N(R6)—C(═O)—R7, —N(R6)—C(═O)—NY3Y4, —N(R6)—C(═O)—OR7, —N(R6)—SO2—R7, —N(R6)—SO2—NY3Y4 and one or more halogen a toms ; R3 represents hydrogen, aryl, cyano, halo, heteroaryl, lower alkyl, —C(═O)—OR5 or —C(═O)—NY3Y; and X1 represents N, CH, C-halo, C—CN, C—R7, C—NY3Y4, C—OH, C—Z2R7, C—C(═O)—OR5, C—C(═O)—NY3Y4, C—N(R8)—C(═O)—R7, C—SO2—NY3Y4, C—N(R8)—SO2—R7, C-alkenyl, C-alkynyl or C—NO2; and their prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs, as well as to novel compounds within the scope of formula (I). Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit protein kinases.
